Bausch+Lomb Results Presentation Deck
Reconciliation of Reported Revenue to Constant Currency Revenue¹ and
Constant Currency Revenue Growth¹ ($M)
Bausch + Lomb
Vision Care²
Surgical
Pharmaceuticals²
Total Bausch + Lomb
Bausch + Lomb
Vision Care²
Surgical
Pharmaceuticals²
Total Bausch + Lomb
BAUSCH+ LOMB
1.
2.
3.
$
$
$
$
Calculation of Constant Currency Revenue for the Three Months Ended
June 30, 2023
June 30, 2022
Revenue as
Reported
646
195
194
1,035
Revenue as
Reported
1,233
378
Changes in
Exchange Rates³
355
1,966
$
$
15
1
$
2
18
Changes in
Exchange Rates³
$
Constant Currency
Revenue (Non-
GAAP)¹
35
7
7
49
$
$
Calculation of Constant Currency Revenue for the Six Months Ended
June 30, 2023
June 30, 2022
661
196
$
196
1,053
Constant Currency
Revenue (Non-
GAAP)¹
$
$
1,268
385
362
2,015
$
Revenue as
Reported
$
588
184
169
941
Revenue as
Reported
1,148
358
324
1,830
$
$
$
$
Change in
Reported Revenue
Amount
58
11
25
94
Change in
Reported Revenue
Amount
Pct.
85
20
31
136
Pct.
10%
6%
15%
10%
7%
6%
10%
7%
Change in
Constant Currency Revenue ¹
$
$
Amount
$
73
12
27
112
Amount
Pct.
Change in
Constant Currency Revenue
120
27
38
185
Pct.
12%
7%
This is a non-GAAP measure or non-GAAP ratio. See Slide 1 and Non-GAAP Appendix for further information on non-GAAP measures and ratios.
Effective in the first quarter of 2023, certain products historically included in the reported results of the Pharmaceuticals segment are now included in the reported results of the Vision Care segment and certain products included in the
reported results of the Vision Care segment are now included in the reported results of the Pharmaceuticals segment. Management believes these movements are necessary in order to better align these products with the groupings of similar
products. The net impact of these product movements was not material to the periods presented. Prior period presentations of segment revenues have been conformed to the current segment reporting structure.
The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported revenues revalued using the
monthly average currency exchange rates during the comparable prior period.
16%
12%
10%
8%
12%
10%
33View entire presentation